Katherine (Kathy) Pappas focuses her practice on intellectual property matters, particularly in patent litigation within the life sciences sector. Kathy handles matters involving a large variety of technologies, ranging from mechanical inventions (e.g., microfluidic devices; injector pens) to pharmaceutical litigation under the Hatch-Waxman Act.
Assisted trial team in obtaining a verdict finding an injector pen for insulin delivery did not infringe Sanofi’s patent, and further finding Sanofi’s patent invalid (Sanofi-Aventis v. Mylan (D.N.J.))*
*Matter handled prior to joining McDermott.
University of California Los Angeles School of Law, JD, 2019
Hampshire College, BA, Psychology with a minor in Cognitive Neuroscience, 2012
Courts / Agencies
US District Court for the Southern District of California
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.